Percutaneous repair of mitral valve regurgitation in patients with severe heart failure: comparison with optimal medical treatment.
Nicolas GeisPhilip RaakeMarkus LeweningDerliz MerelesEmmanuel ChorianopoulosLutz FrankensteinHugo A KatusRaffi BekeredjianSven T PlegerPublished in: Acta cardiologica (2017)
Both OMT and PMVR cause cardiac reverse remodelling and relief of symptoms in patients with HF and severe MR. PMVR results in significant additional cardiac reverse remodelling compared to pharmacologically-only managed patients.
Keyphrases
- mitral valve
- heart failure
- left ventricular
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- healthcare
- early onset
- prognostic factors
- peritoneal dialysis
- magnetic resonance
- atrial fibrillation
- left atrial
- aortic stenosis
- acute heart failure
- minimally invasive
- coronary artery disease
- patient reported outcomes
- drug induced
- computed tomography
- smoking cessation
- transcatheter aortic valve replacement